Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata-shi, Niigata, Japan.
PLoS One. 2023 Mar 15;18(3):e0283070. doi: 10.1371/journal.pone.0283070. eCollection 2023.
Nasal breathing disorders are associated with obstructive sleep apnea (OSA) syndrome and influence the availability of continuous positive airway pressure (CPAP) therapy. However, information is scarce about the impact of nasal resistance assessed by rhinomanometry on CPAP therapy. This study aimed to examine the relationship between CPAP adherence and nasal resistance evaluated by rhinomanometry, and to identify clinical findings that can affect adherence to CPAP therapy for patients with OSA. This study included 260 patients (199 men, 61 women; age 58 [interquartile ranges (IQR) 50-66] years) with a new diagnosis of OSA who underwent rhinomanometry (before, and 1 and 3 months after CPAP introduction) between January 2011 and December 2018. CPAP use was recorded, and the good and poor CPAP adherence groups at the time of patient registration were compared. Furthermore, those with improved and unimproved pre-CPAP high rhinomanometry values were also compared. Their apnea-hypopnea index (AHI) by polysomnography at diagnosis was 45.6 (IQR 33.7-61.6)/hour, but the residual respiratory event (estimated AHI) at enrollment was 2.5 (IQR 1.4-3.9)/hour and the usage time was 318 (IQR 226-397) minutes, indicating that CPAP was effective and adherence was good. CPAP adherence was negatively correlated with nasal resistance (r = -0.188, p = 0.002). The participants were divided into good (n = 153) and poor (n = 107) CPAP adherence groups. In the poor adherence group, rhinomanometry values before CPAP introduction were worse (inspiration, p = 0.003; expiration, p = 0.006). There was no significant difference in patient background when comparing those with improved (n = 16) and unimproved (n = 12) pre-CPAP high rhinomanometry values. However, CPAP usage time was significantly longer in the improved group 1 month (p = 0.002) and 3 months (p = 0.026) after CPAP introduction. The results suggest that nasal resistance evaluated by rhinomanometry is a useful predictor of CPAP adherence, and that improved rhinomanometry values may contribute to extending the duration of CPAP use.
鼻腔通气障碍与阻塞性睡眠呼吸暂停(OSA)综合征有关,并影响持续气道正压通气(CPAP)治疗的效果。然而,关于鼻阻力评估对 CPAP 治疗的影响的信息很少。本研究旨在检查 CPAP 顺应性与鼻阻力之间的关系,并确定可影响 OSA 患者 CPAP 治疗顺应性的临床发现。本研究纳入了 260 例(男 199 例,女 61 例;年龄 58 [四分位距(IQR)50-66]岁)新诊断为 OSA 的患者,他们于 2011 年 1 月至 2018 年 12 月间接受了鼻阻力测试(CPAP 引入前、1 个月和 3 个月后)。记录 CPAP 使用情况,并比较患者登记时 CPAP 顺应性良好和差的组。此外,还比较了高鼻阻力值在 CPAP 引入前改善和未改善的患者。他们的多导睡眠图诊断时的呼吸暂停低通气指数(AHI)为 45.6(IQR 33.7-61.6)/小时,但登记时的残余呼吸事件(估计 AHI)为 2.5(IQR 1.4-3.9)/小时,使用时间为 318(IQR 226-397)分钟,表明 CPAP 有效,顺应性良好。CPAP 顺应性与鼻阻力呈负相关(r = -0.188,p = 0.002)。将参与者分为 CPAP 顺应性良好(n = 153)和差(n = 107)组。在 CPAP 顺应性差的组中,CPAP 引入前的鼻阻力值更差(吸气时,p = 0.003;呼气时,p = 0.006)。比较高鼻阻力值 CPAP 引入前改善(n = 16)和未改善(n = 12)的患者时,患者背景无显著差异。然而,改善组 CPAP 引入后 1 个月(p = 0.002)和 3 个月(p = 0.026)时的 CPAP 使用时间明显延长。结果表明,通过鼻阻力评估的鼻阻力是 CPAP 顺应性的有用预测指标,改善的鼻阻力值可能有助于延长 CPAP 使用时间。